Rallybio Corp
RLYB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001739410
No open-market purchases or sales by Rallybio Corp insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $65.0M in total; Viking Global Investors is the only superinvestor holding it.
Holders of 5% or more of RLYB
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Rallybio Corp, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Rallybio Corp on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
1 Schedule 13D or 13G filing on Rallybio Corp, newest first, including old-format filings without a stake.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Rallybio Corp shares.
No Form 144 notices for Rallybio Corp are on file.